NANOVESICLES WITH 8% CAFFEINE, 8% NIACINAMIDE, 500 ppm DDBD PEPTIDE
An innovation designed for the deepest dermal routine, featuring 100–300 nm lipid bilayer shell technology that is highly compatible with the skin’s stratum corneum. It is engineered for controlled and slow release into the dermal layer, while enhancing bioavailability and bio-efficacy, and offering high stability against light, heat, and high-shear processing.
Synthetic tripeptide that mimics Waglerin-1, a neurotoxin that targets muscle receptors. Dipeptide Diaminobutyroyl Benzylamide Diacetate works by inhibiting muscle contractions in the skin, which are responsible for expression lines and dynamic wrinkles.
Targets nicotinic acetylcholine receptors (nAChR) on muscle cells. Blocks signal transmission responsible for muscle contraction. Reduces repeated facial movement stress. Visible reduction of dynamic wrinkles
Purified Caffeine, Inhibits phosphodiesterase (PDE) increases intracellular cAMP. Supports mitochondrial activity and ATP production.Enhances skin vitality and firmness
Mimics Waglerin-1 activity by targeting nAChR receptors and reducing muscle contraction signals associated with dynamic wrinkles.
Inhibits PDE to increase cAMP, stimulates cellular metabolism, enhances microcirculation, and protects against oxidative stress.
Enhances ceramide synthesis, reduces inflammatory signaling, inhibits melanosome transfer, and supports NAD⁺ metabolism
AVERAGE NANOPARTICLE SIZE
ENTRAPMENT EFFICACY
Zeta-Potential
Optimized Penetration Dimension with 100 – 300 nm , each niosome is small enough to navigate the intercellular lipid pathway of the stratum corneum while remaining large enough to avoid systemic absorption, maintaining a topical-localized action. It’s enhanced deposition in the viable epidermis and upper dermis and superior bioavailability of both hydrophilic and lipophilic actives through dual-phase distribution.
TDDS offered the controlled release diffusion with deepest penetration to deliver encapsulated active ingredients through stratum corneum barrier functioned to target cells as Melanocyte, Keratinocyte, Basal layer, Fibroblast and Mast cells.
